Mutant p53 suppresses innate immune signaling to promote tumorigenesis

Monisankar Ghosh1, Suchandrima Saha1, Julie Bettke2

  • 1Stony Brook Cancer Center, Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11790, USA.

Cancer Cell
|February 5, 2021
PubMed

Insights

Mutant p53 (mtp53) suppresses innate immune signaling by inhibiting TBK1, promoting cancer cell survival and immune evasion. Restoring TBK1 function can eliminate mtp53 tumors by reactivating anti-tumor immunity.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Mutant p53 (mtp53) proteins possess cancer-promoting gain-of-function activities.
  • Cancer cells utilize various mechanisms to evade immune surveillance and promote survival.
  • The innate immune system, particularly the cGAS-STING-TBK1-IRF3 pathway, plays a crucial role in anti-tumor immunity.

Purpose of the Study:

  • To elucidate the mechanism by which mtp53 promotes cancer cell survival and immune evasion.
  • To investigate the interaction between mtp53 and the cytoplasmic DNA sensing machinery.
  • To explore therapeutic strategies targeting mtp53-mediated immune suppression.

Main Methods:

  • Investigated the interaction of mtp53 with components of the cGAS-STING-TBK1-IRF3 pathway.
  • Assessed the effect of mtp53 on TBK1 complex formation with STING and IRF3.
  • Analyzed changes in cytokine production and IRF3 transcriptional activity.
  • Evaluated the impact of restoring TBK1 signaling on cancer cell eradication.

Main Results:

  • Mutant p53 (mtp53), unlike wild-type p53, binds to TANK-binding protein kinase 1 (TBK1).
  • Mtp53 binding prevents the formation of the essential TBK1-STING-IRF3 complex, inhibiting IRF3 activation and nuclear translocation.
  • This interference with innate immune signaling leads to altered cytokine production and immune evasion by cancer cells.
  • Restoration of TBK1 signaling effectively bypasses mtp53's suppressive effects, leading to restored immune cell function and cancer cell eradication.

Conclusions:

  • Mutant p53 actively suppresses innate immune signaling through direct inhibition of the TBK1-STING-IRF3 axis.
  • Mtp53-mediated immune suppression contributes to cancer cell survival and evasion of tumor immunity.
  • Therapeutic strategies aimed at restoring TBK1 signaling hold promise for reactivating anti-tumor immune responses and eliminating mtp53-driven cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K